These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 3149170
1. Serum copper concentration as an index of cardiopulmonary injury in monocrotaline-treated rats. Molteni A, Ward WF, Ts'ao CH, Fitzsimons EJ. Ann Clin Lab Sci; 1988; 18(6):476-83. PubMed ID: 3149170 [Abstract] [Full Text] [Related]
2. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817. Molteni A, Ward WF, Ts'ao CH, Solliday NH. Proc Soc Exp Biol Med; 1986 Sep; 182(4):483-93. PubMed ID: 3016747 [Abstract] [Full Text] [Related]
3. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617. Molteni A, Ward WF, Ts'ao C, Solliday NH. Arch Int Pharmacodyn Ther; 1988 Sep; 291():21-40. PubMed ID: 3129998 [Abstract] [Full Text] [Related]
4. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Ward WF, Molteni A, Ts'ao CH. Radiat Res; 1989 Feb; 117(2):342-50. PubMed ID: 2922477 [Abstract] [Full Text] [Related]
5. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026. Molteni A, Ward WF, Ts'ao CH, Hinz JM. Biochem Pharmacol; 1989 Aug 01; 38(15):2411-9. PubMed ID: 2547380 [Abstract] [Full Text] [Related]
6. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline. Shubat PJ, Hubbard AK, Huxtable RJ. J Toxicol Environ Health; 1989 Aug 01; 28(4):445-60. PubMed ID: 2531804 [Abstract] [Full Text] [Related]
7. Monocrotaline pneumotoxicity in mice. Molteni A, Ward WF, Ts'ao CH, Solliday NH. Virchows Arch B Cell Pathol Incl Mol Pathol; 1989 Aug 01; 57(3):149-55. PubMed ID: 2570481 [Abstract] [Full Text] [Related]
8. Serum copper concentration as an index of lung injury in rats exposed to hemithorax irradiation. Ward WF, Molteni A, Fitzsimons EJ, Hinz J. Radiat Res; 1988 Jun 01; 114(3):613-20. PubMed ID: 3287430 [Abstract] [Full Text] [Related]
9. Serum copper concentration as an index of experimental lung injury. Ward WF, Molteni A, Ts'ao C, Ischiropoulos H. Adv Exp Med Biol; 1989 Jun 01; 258():287-302. PubMed ID: 2516709 [Abstract] [Full Text] [Related]
10. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin. Ganey PE, Sprugel KH, Hadley KB, Roth RA. J Pharmacol Exp Ther; 1986 Apr 01; 237(1):226-31. PubMed ID: 2937908 [Abstract] [Full Text] [Related]
11. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole. Schultze AE, Roth RA. Toxicol Appl Pharmacol; 1993 Jul 01; 121(1):129-37. PubMed ID: 7687795 [Abstract] [Full Text] [Related]
12. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury. Bruner LH, Johnson K, Carpenter LJ, Roth RA. J Toxicol Environ Health; 1987 Jul 01; 21(1-2):205-17. PubMed ID: 3573071 [Abstract] [Full Text] [Related]
13. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Molteni A, Ward WF, Ts'ao CH, Solliday NH, Dunne M. Proc Soc Exp Biol Med; 1985 Oct 01; 180(1):112-20. PubMed ID: 2994075 [Abstract] [Full Text] [Related]
14. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension. Langleben D, Carvalho AC, Reid LM. Am Rev Respir Dis; 1986 May 01; 133(5):789-91. PubMed ID: 3085563 [Abstract] [Full Text] [Related]
15. Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Todd L, Mullen M, Olley PM, Rabinovitch M. Pediatr Res; 1985 Jul 01; 19(7):731-7. PubMed ID: 3161000 [Abstract] [Full Text] [Related]
16. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice. Hebert C. Toxic Rep Ser; 1993 Jul 01; 29():1-D3. PubMed ID: 12209195 [Abstract] [Full Text] [Related]
17. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs. Gillespie MN, Dyer KK, Olson JW, O'Connor WN, Altiere RJ. Res Commun Chem Pathol Pharmacol; 1985 Dec 01; 50(3):365-78. PubMed ID: 3936139 [Abstract] [Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653 [Abstract] [Full Text] [Related]
19. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Yuyama H, Fujimori A, Sanagi M, Koakutsu A, Sudoh K, Sasamata M, Miyata K. Eur J Pharmacol; 2004 Aug 02; 496(1-3):129-39. PubMed ID: 15288584 [Abstract] [Full Text] [Related]
20. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Langleben D, Reid LM. Lab Invest; 1985 Mar 02; 52(3):298-303. PubMed ID: 3156262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]